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Summary of Main Points
To avoid misinterpretation, it is vital at the outset to emphasise that:
(i) information in this Report relates to those problem drug users who present for
treatment rather than all those who have drug problems, or indeed all those who use
drugs;
(ii) like most health service data, the information is service dependent and the picture it
provides of the extent and nature of drug problems will be influenced by drug service
provision;
(iii) the Report does not reflect non-treated drug misuse. Thus this Report should not be
considered as portraying the total picture of drug use, but as providing a key element of
that picture. The data may be particularly useful when considered in conjunction with
results from any surveys which might be undertaken and other research.
Main Points
• The number of cases, as distinct from persons, who were treated for problem drug
misuse in the Greater Dublin Area in 1992 was 2,555 and in 1993 the number was
2,919.
• The estimated number of persons who were treated in 1992 was 2,240 and 2,573 in
1993. (See Appendix E).
• The number of clients who presented for treatment for the first time ever was 668 in
1992 and 859 in 1993.
• Three quarters of clients were male.
• Most clients (96 per cent in 1992 and 97 per cent in 1993) were between the ages of 15
and 39 years of age.
• Six out of ten lived with their family of origin.
• Eight out of ten were unemployed.
• Approaching four out of ten had left school before the official school leaving age of 15.
• In 1992 twenty-eight per cent lived in the inner city. This increased to 31 per cent in
1993.
• In the majority of cases opiates (mainly heroin and morphine sulphate tablets) were the
drugs which caused the most problems and for which clients sought treatment (75 per
cent in 1992, 80 per cent in 1993).
• Six out of ten clients had injected their primary drug.
• Of those who had ever injected their drugs, more than seven out of ten were currently
injecting, but only one-fifth were currently sharing injecting equipment.
• Significant differences were observed between males and females on a number of
variables. Females were less likely than males to be living in their families of origin;
more likely to be living with a drug abusing partner than were the males and were
found proportionately more likely to be sharing injecting equipment.
CHAPTER 1
Introduction
This report is the third in the series of reports which analyse the characteristics of drug users
who presented for treatment in the Greater Dublin Area. Individual reports were published for
the years 1990 and 1991 while this present one is concerned with the two-year period 1992
and 1993, thus presenting the most up-to-date information available on treated drug misuse in
the Greater Dublin Area. The report is based on those data returned to the Drug Section of the
Health Research Board by the participating treatment centres for the years 1992 and 1993.
The object or rationale for this report, as was that of previous reports, is to provide ongoing
information to facilitate the understanding of the epidemiology of treated drug misuse and to
provide data useful to policy makers on the healthcare and social implications of drug misuse.
Because of the sensitive and confidential nature of the relationship between the drug misuser
and the treatment centres, there are obvious constraints on the kind of information which can
be gathered. The time constraints on the staff at the treatment centres completing
questionnaires to furnish the Drug Section with data are also a factor in the extent of
information which can be collected.
The first report in the series on treated drug misuse in the Greater Dublin Area was based on
1990 data (l). That report presented an introduction and background to the area of drug
misuse in Ireland; supplied information on the history of drug misuse in Dublin, on the role of
the Pompidou Group in collaborative research, the pilot drug treatment reporting system in
Dublin and London and also on the Government’s role and policy on drug misuse. To provide
a framework for the data in this present report it would be helpful to refer to that earlier
report. However, briefly, the Cooperation Group to Combat Drug Abuse and Illicit
Trafficking in Drugs (the Pompidou Group) was formed in 1971 following a proposal made
by M. Georges Pompidou, the then President of the French Republic, to his colleagues in the
European Community. Epidemiologists from a number of countries and a number of different
backgrounds met to explore how administrative monitoring systems could be established to
enable them to assess public health and social problems associated with drug misuse. Work
on the actual collection of data on drug misuse in Western Europe dates from March 1980
when the Committee of Ministers of the European Community authorised interested States to
enter into a Partial Agreement for the purpose of continuing within the Council of Europe the
Cooperation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (the Pompidou
Group). Dublin was included in the first report of the Multi-city Study of Drug Misuse in
Europe (2) which had taken place in seven European cities. That report, which was published
by the Council of Europe in 1987, brought together information from a range of different
indicators of drug misuse activity, for example, first treatment demand, drug related deaths,
persons charged with drug offenses and some indication of the price and purity of drugs in
each of the cities. Information on persons in receipt of treatment for problem drug use was
identified in that first multi-city study as one of the most important areas of information.
Following that a questionnaire was drafted and used in a pilot study (by O’Hare and Hartnoll
in 1989 (3)). Subsequently this questionnaire was used in the drug treatment reporting system
established in Dublin in 1990. The findings of that pilot study were the basis for the
subsequent data collection in Dublin and the reports of 1990, 1991 and the current 1992 and
1993 report.
The second Multi-city Study of Drug Misuse in Europe (4) was published in 1993 and
involved 13 European cities, including Dublin. This multi-city approach which reviews drug
misuse trends in different cities within a comparative framework is now being extended to
include countries in Central and Eastern Europe.
The goals of the Expert Epidemiology Group, as set out in the Definitive Protocol of the
Pompidou Group, for the future development and use of treatment reporting systems are as
follows:
(1) to improve the quality, usefulness and comparability of epidemiological data collection
on drug misuse in Europe;
(2) to collate up-to-date epidemiological information and to compare and interpret trends
in drug misuse in different European countries.
Returning to this present series, the second report Treated Drug Misuse in the Greater Dublin
Area, 1991 (5), while concentrating on treated drug misuse, elaborated on the further action
taken, which included the publication in 1989 of the previously mentioned O’Hare and
Hartnoll study and the continuing activities of the Pompidou Group.
The Definitive Protocol will be used as a basis for the collection of the 1995 treatment data in
Dublin and elsewhere in Ireland. That Protocol contains an amended questionnaire but one
which is not markedly different from the one in current use, together with detailed
instructions for the recording of these data.
In the Irish context the need for the provision of on-going reliable data was acknowledged in
the Government Strategy to Prevent Drug Misuse (6). As was stated in previous reports in this
present series, the data collected and analysed in this report can also be of use to a range of
service providers in the area of drug misuse. Bodies such as the Department of Health, the
Eastern Health Board and the statutory and voluntary bodies who participate in the treatment
of problem drug users should find it particularly valuable.
METHODOLOGY
There are three main categories into which the data fall:
(a) Total Treatment Contacts – refers to the routine reporting of all clients receiving
treatment during the year, including the Census data;
(b) Census of Clients in Treatment – refers to clients in treatment in a residential
centre on a particular day, i.e. 31 December prior to the year in question; and to
non- residential clients, those who received treatment at least once during the
month of December, again prior to the appropriate year;
(c) First Treatment Contacts – refers to a subset of clients who, during the year in
question, entered treatment for the first time, never having had previous
treatment anywhere for problem drug use.
For each of these three categories, data will be analyzed on the basis of:
(i) socio-demographic characteristics;
(ii) history of drug misuse;
(iii) injecting and needle-sharing practices.
The socio-demographic variables included for the purposes of this report are: age of client;
sex of client; living status of client; employment status of client and finally education. The
inclusion of and confinement to these particular socio-demographic variables is influenced by
the choice of these variables by the Pompidou Group as being the most relevant in the data it
was possible for their treatment reporting systems to collect. Frequency Tables are in
Appendix A and population figures are noted in Appendix B.
The geographical area covered by the study is the Greater Dublin Area, comprising
approximately 504km2 within the County of Dublin. This area encompasses Dublin County
Borough, its north suburbs (Fingal part), its south suburbs (Belgard part) and also
Dunlaoghaire County Borough and its suburbs. The total population of the area under study,
according to the Ireland, Census of Population, 1991, is 915,516 persons.
This Report then is concerned with persons resident in the Greater Dublin Area who received
treatment during 1992 or 1993 at any one of the 22 centres participating in the reporting
system. Between them they cover a range of services and facilities including both medical and
non-medical care. Some of these centres are statutory bodies and some are voluntary.
(Appendix C lists the centres and briefly describes the services they provide). The Satellite
Clinics were set up in 1992 and 1993. Baggot Street Clinic made returns in 1992 and returns
from Aisling and City Clinic commenced in 1993. As in the previous Reports, from our
knowledge of service providers in the catchment area, it is felt that the centres who have
returned data represent almost complete coverage of treated drug misuse. However, there are
some gaps, as some centres were unable to send returns and also there is always the group of
users who may not be included because they are receiving treatment from either general
practitioners or agencies not participating in our reporting system.
DEFINITIONS USED IN THIS REPORT
Drug misuse
The working definition of drug misuse used in this Report is:
The taking of a legal and/or illegal drug or drugs (excluding alcohol other than as a
secondary drug of misuse, and tobacco) which harm the physical, mental or social well-
being of the individual, the group or society.
drug treatment
The definition of treatment is:
any activity which is targeted directly at people who have problems with their drug use
and which aims to ameliorate the psychological, medical or social state of individuals
who seek help for their drug problems. This activity will often take place at specialised
facilities for drug users, but may also take place in general services offering
medical/psychological help to people with drug problems.
Various therapies are used in the treatment of clients at the centres. These range from medical
treatments, (such as detoxification, methodone programmes or drug-free programmes) to non-
medical therapies which can include addiction counselling, group therapy and psychotherapy.
Therapies are generally provided by professionally qualified personnel, but some centres may
deem certain persons, who are not professionally qualified, as suitable to undertake some of
these therapies. Apart from the therapeutic centres, drug treatment may be provided in
hospitals, therapeutic communities, residential  centres, out-patient clinics, street agencies,
general practitioners and, of course, in the prisons. Under the definition of ‘treatment’ used in
this report, information given over the telephone, or information solely concerned with
queries about social welfare entitlements or benefits are not included as ‘treatment’.
Primary Drug
The primary drug is defined as the drug which, at the time of the current treatment contact,
the client alleges is causing most problems and for which he or she has sought treatment.
DATA COLLECTION
A questionnaire (a copy of which is included in Appendix D) is completed by each of the
treatment centres for each of their clients. This questionnaire has been used for the previous
reports so the data examined are similar for each of the years. The questionnaire was
originally designed for the previously mentioned Dublin/London pilot project. Prior to the
commencement of that study, considerable public relations work was undertaken to identify
and then ensure participation of centres providing treatment to drug users. In obtaining the
cooperation of the treatment centres, the objectives and the value of assembling and reporting
on the data were discussed and assurances regarding the confidential nature of the data were
given. No information from an individual participating centre would ever be divulged without
the prior consent of that centre. No names appear on the questionnaires. Scalable plastic bags
are provided to each treatment centre for return of completed questionnaires. The
questionnaires are then checked and this, in some instances, involves clarification with
particular treatment centres. Information used refers to cases, not to individuals. This is
necessary since a client could be receiving treatment from more than one centre and the
anonymity of the system prevents determination of which clients are attending more than one
centre. This introduces an element of double-counting and consequently an estimation of the
rates for treated drug misuse is given in Appendix E.
For the years 1992 and 1993, which are the subject of this Report, no information was
received from four and six of the participating treatment centres respectively.
Data were collected on the three previously mentioned categories, firstly on Census or Point
Treated Prevalence and these Census data refer to persons in treatment on a particular day or
during a particular time period. This is rather similar to information from a census of the
general population. Information from a census count is of interest because it is a count of the
number of clients in treatment at a particular point in time. The profile of these clients tends
to be different from that of the other clients in treatment, for example, Census clients appear
to be older and have been using their primary drug for a longer period of time. Where Total
Treatment Contacts were concerned these data refer to all persons who received treatment for
their problem drug misuse at any time during the calendar year of 1992 or 1993 and include
the Census clients of the previous December. The third group of clients is the group of First
Treatment Contacts or One Year Treated Incidence. Data on persons who entered treatment
for the first time ever during 1992 or 1993 are included under this heading. Over time first
treatment data can point to changing patterns of more severe problematic drug use. New sub-
populations of drug misusers who are coming into treatment for the first time can be
identified from the usually older population of more chronic drug users who may repeatedly
go in and out of treatment over periods of several years.
CHAPTER DETAILS
Chapter 2 focuses on data obtained on the one-year treated prevalence of clients who attended
the treatment clinics – total treatment contacts covering their socio-demographic background,
the history of their drug misuse and their sharing and injecting behaviour. Each year will be
commented upon and compared with the results for the other year. In Chapter 3 the emphasis
is on point-treated prevalence, that is clients in treatment on a census date. Again the socio-
demographic data on these clients are noted, the history of their drug misuse and their sharing
and injecting behaviour. For Chapter 4, a similar approach as in the two previous chapters
will be taken on clients who were first treated in 1992 or 1993. Chapter 5 will discuss the
graphs which are based on the data, first on total treatment clients and then on the
comparisons between the census clients and the first treatment clients. The final chapter will
contain our concluding remarks.
CHAPTER 6
Concluding Remarks
This Report on treated drug misuse in the Greater Dublin Area in the years 1992 and 1993
used data returned by the treatment centres. These data then relate to those problem drug
users who present for treatment rather than all those who have drug problems, or indeed all
those who use drugs. The results of the analysis confirm most of what is already known about
problem drug users who present for treatment.
The proportion of clients presenting for treatment in 1993 had increased over the 1992 figure
by 14 per cent.
There was also a small increase in the proportion of clients who lived in the inner city -from
28 per cent in 1992 to 31 per cent in 1993. As in previous years, clients were characterised by
levels of unemployment and low education far in excess of those for the population in
general.
As would be expected, opiates remained the drugs for which most of the clients sought
treatment. Again the proportion in 1993 was somewhat higher than in 1992 – 80 per cent in
contrast with 75 per cent. Isolating the younger First Contact group, while they would have a
smaller proportion of problem opiate users than the total treated population, they showed a
large increase in opiate use as their primary drug – from 45 per cent in 1992 to 64 per cent in
1993. No doubt consequent on that increase, the proportion of those injecting their primary
drug in the First Contact group increased from 34 per cent in 1992 to 44 per cent in 1993.
This group also showed an increase in the proportion first using in the 15-19 year age group
(55 per cent in 1992 to 61 per cent in 1993) and in the duration of use before presenting for
treatment (46 per cent in 1992 to 53 per cent in 1993).
Overall eighty-three per cent of the 1992 clients had injected their primary drug at some
stage. The proportion for 1993 was similar at 82 per cent. Of those who had ever shared the
proportion in this group for 1992 was 59 per cent and 60 per cent in 1993. Again isolating the
First Contact group, whom it will be remembered include the younger misusers, the
comparative proportions for that group for those who had ever injected were: 1992 – 41 per
cent: 1993 – 50 per cent. For sharing, the proportions for 1992 and 1993 were 19 per cent and
25 per cent respectively.
On the use of specific types of drugs, the rise is chiefly in the use of opiates (mainly heroin
and morphine sulphate tablets) and here the increase in the number of teenagers using opiates
would cause concern. Fifty-one per cent of all teenagers coming for treatment for the first
time in 1993 had been misusing opiates. Also regarding this younger group of clients coming
for treatment for the first time, a high proportion are using hallucinogens, mainly ecstasy and
to a lesser extent LSD. Ecstasy, of course, is a fairly recent arrival on the market and has
become associated with socialising. It therefore may have more appeal than other drugs to the
younger group. Among the very young clients (under 15s), there was a sub-group of users of
volatile inhalants but the drug most likely to be used by these clients was cannabis. It must be
emphasised that the number of clients who were under 15 and were receiving treatment was
very small. Nevertheless the situation of these young people must be grounds for worry. One
other particularly disturbing finding in relation to teenagers was that over 60 per cent of those
who had ever injected in the 15-19 year age group were currently injecting in 1992 and this
had risen to 72 per cent in 1993. Isolating the first contact group, the proportions were similar
for that group. However, a higher proportion of those currently injecting were in the first
contact group in 1993 than there were in 1992 – 42 per cent in 1992 and 49 per cent in 1993.
The most probable profile of the problem drug user would be that of a young, unemployed
male, living in a deprived city area misusing heroin. However, we found teenagers to be a
particularly at-risk group with a disturbing number of them injecting heroin. Since
Department of Health records show that half of those who test positive for HIV are
intravenous drug users, the importance of targeting this group of very young drug users with
prevention and education programmes need hardly be stressed. While the schools’
programmes may reach a substantial number of young people, these programmes may be
inadequate to reach the group who have already left school before the official school-leaving
age. Over one-third of the total number of clients treated in both 1992 and 1993 would be in
this group of early school-leavers.
There were significant differences between the characteristics of the male and female clients.
For instance, male clients were more likely to be still living with their families of origin.
Another difference between the sexes was that proportionately more female clients were
living with a drug using partner than were male clients. What may or may not have followed
from that particular situation was that females were proportionally more likely to be sharing
injecting equipment than males. ‘Sharing’ is, however, a problematic concept as drug users
may define it differently. For instance, some do not regard sharing injecting equipment with a
partner as sharing. Only when the person with whom they share needles is outside of their
circle would they define that as ‘sharing’. Another characteristic on which females differed
from males was that, particularly in the First Contact group, they were more likely to be
younger coming for treatment and in 1992 proportionately three times more likely to be still
in school. The implication from this finding is that girls are more likely than boys to be
receiving treatment for problem drug use while still at school. Whereas in 1993 the difference
between boys and girls was not as great as in the previous year, it was still considerable.
The differing proportions of men and women coming for treatment, in that males are three
times more likely to be receiving treatment than females, may or may not reflect the types and
adequacy of services provided. It may be true that women in Dublin are less likely to become
involved in drug misuse anyway. Without research into such a possibility it is impossible to
come to a satisfactory conclusion. There was a continuing rise in the numbers attending the
treatment centres for all the groups of clients involved. This could, however, be a reflection of
an expansion of the services available. For instance, during the period under review in this
Report services were developed by the Eastern Health Board with the opening of three
satellite clinics. On the other hand, the number of first contact clients or incidence is a good
indicator of increasing or decreasing numbers coming into treatment and these have
substantially increased. We do not know whether or not these figures reflect a rise in drug
misuse in the general population.
We have referred on a number of occasions throughout the report to our intention of
producing a five-year report in 1995 covering the years 1990 to 1994 to examine trends in
regard to various socio-demographic characteristics, the history and practices associated with
drug misuse and the durations of misuse. The data are, of course, service dependent so the
picture they provide of the extent and nature of drug problems will be influenced by drug
service provision. Whether this provision accounts totally for the increasing numbers is a
question needing further investigation.
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